Image

Phase II Randomized Double-Blind Study of mFOLFIRINOX plus Ramucirumab versus mFOLFIRINOX plus placebo in Advanced Pancreatic Cancer Patients HCRN GI14-198

Investigating the Effects of Adding Investigational Medication to Chemotherapy for Prostate Cancer (PCA)

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the effects of adding an investigational medication to the usual chemotherapy regimen for patients with prostate cancer (PCA). Prostate cancer is a disease where cancer cells form in the tissues of the prostate. The study aims to understand the positive or negative effects of this combination treatment on the participants.

Participants will be randomly assigned to different study arms. Some will receive the investigational medication along with their regular chemotherapy, while others may receive a placebo. A placebo is an inactive substance that looks like the investigational medicine but does not contain any medicine. This helps researchers compare the effects of the investigational medicine to those of the standard treatment.

  • Who can participate: Adults with a diagnosis of prostate cancer with metastatic or recurrent disease can participate. They must have a life expectancy greater than 12 weeks and adequate organ function.
  • Study details: Participants will be assigned to receive either the investigational medication with chemotherapy or a placebo. The placebo is an inactive substance that resembles the investigational medication but has no therapeutic effect. Participants will not be compensated for their involvement in the study.
Print
Study details
    pancreatic cancer

TX7486

19 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.